Get started
mrezaei

Possible Long Opportunity

Sarepta Therapeutics, Inc. (NASDAQ:SRPT)  
mrezaei  
NASDAQ:SRPT   Sarepta Therapeutics, Inc.
2
0
SRPT is already almost oversold but I think $24.2 would be a good level to buy for a long position, lets see...
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.